Cuorips Inc.

4894

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-13FY2027 Q1

Revenue

1.3100M JPY

YoY -50.6%

Operating Income

-3.3100M JPY

YoY -69.7%

Net Income

-11.4100M JPY

YoY -74.8%

EPS

-38.5JPY

YoY -55.9%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2.1億円

-1.1億円

-4.3億円

-7.6億円

-10.8億円

Rev: 38.3百万円Op: -4.5億円NI: -4.5億円

Rev: 23.1百万円Op: -5.9億円NI: -6.3億円

Rev: 1.8億円Op: -5.9億円NI: -6.4億円

Rev: 2.1億円Op: -10.8億円NI: -10.2億円

2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income55.6%

Revenue Progress1M

Revenue Forecast5.400M

Net Income Progress-3.200M

Net Income Forecast-5.700M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan